Ryuji Ueno
Founder bei S&R Foundation
Profil
Ryuji Ueno was the founder of R-Tech Ueno, Ltd.
(founded in 1989) where he held the title of President from 1989 to 2003.
He was also the founder of Sucampo GmbH (founded in 1997) where he held the title of Chairman & Chief Executive Officer from 2011 to 2014.
Additionally, he is the founder of S&R Technology Holdings LLC (founded in 1999) where he currently holds the title of Managing Member.
Dr. Ueno was also the founder of Sucampo Pharmaceuticals, Inc. (founded in 1996) where he held the title of Chief Executive & Scientific Officer from 2006 to 2014.
He is the founder of S&R Foundation (founded in 2000) and currently holds the title of Honorary Chairman.
Lastly, Dr. Ueno is the founder of VLP Therapeutics LLC (founded in 2012) where he currently holds the title of Chairman & Chief Medical Officer.
He is currently the President of Omotesenke Domonkai Eastern Region USA, Inc. Dr. Ueno obtained a doctorate degree from Keio University and Osaka University.
Aktive Positionen von Ryuji Ueno
| Unternehmen | Position | Beginn |
|---|---|---|
S&R Foundation
 S&R Foundation Miscellaneous Commercial ServicesCommercial Services The S&R Foundation provides support for artists and scientists involved in the arts, sciences, and social entrepreneurship, especially those furthering international and cultural collaboration. The company was founded by Sachiko Kuno and Ryuji Euno in 2000 and is headquartered in Washington, DC. | Founder | 01.01.2000 |
| Omotesenke Domonkai Eastern Region USA, Inc. | President | - |
S&R Technology Holdings LLC
 S&R Technology Holdings LLC Financial ConglomeratesFinance S&R Technology Holdings LLC provide support to global entrepreneurs and new businesses. It offers managing and growing global ventures. The company was founded by Sachiko Kuno and Ryuji Ueno in 1999 and is headquartered in Bethesda, MD. | Founder | 01.01.1999 |
VLP Therapeutics LLC
 VLP Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD. | Founder | 01.01.2012 |
Ehemalige bekannte Positionen von Ryuji Ueno
| Unternehmen | Position | Ende |
|---|---|---|
| SUCAMPO PHARMACEUTICALS, INC. | Chief Executive Officer | 03.03.2014 |
Sucampo GmbH
 Sucampo GmbH Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Sucampo GmbH is a Swiss company that manufactures and distributes pharmaceuticals and health care products. The private company is based in Zug, Switzerland. The company was founded by Ryuji Ueno, Sachiko Kuno. Sucampo was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on December 29, 2010 for $120 million. | Chief Executive Officer | 03.03.2014 |
| R-TECH UENO, LTD. | Founder | 01.01.2003 |
Ausbildung von Ryuji Ueno
| Keio University | Doctorate Degree |
| Osaka University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
R-Tech Ueno, Ltd.
 R-Tech Ueno, Ltd. Pharmaceuticals: MajorHealth Technology R-Tech Ueno Ltd. engages in the research and development, manufacture and sale of pharmaceutical products. It operates through the following business divisions: New Pharmaceutical Research and Development, Pharmaceutical Manufacture and Sale, and Pharmaceutical Development Support and Contract Manufacturing Services. The New Pharmaceutical Research and Development business provides development for unmet medical needs area, orphan drug area, and anti-aging area. The Pharmaceutical Manufacture and Sale business handles the manufacture and sale of Rescula Eye Drops for glaucoma and ocular hypertension. The Pharmaceutical Development Support and Contract Manufacturing Services business covers the manufacture and sale of AMITIZA capsules for chronic idiopathic constipation. It also accepts contract manufacturing of eye drops, liquid drugs and liquid-filled hard capsules. The company was founded by Ryuji Ueno and Sachiko Kuno in September 1989 and is headquartered in Tokyo, Japan. | Health Technology |
S&R Technology Holdings LLC
S&R Technology Holdings LLC Financial ConglomeratesFinance S&R Technology Holdings LLC provide support to global entrepreneurs and new businesses. It offers managing and growing global ventures. The company was founded by Sachiko Kuno and Ryuji Ueno in 1999 and is headquartered in Bethesda, MD. | Finance |
Sucampo Pharmaceuticals, Inc.
 Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Sucampo GmbH
Sucampo GmbH Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Sucampo GmbH is a Swiss company that manufactures and distributes pharmaceuticals and health care products. The private company is based in Zug, Switzerland. The company was founded by Ryuji Ueno, Sachiko Kuno. Sucampo was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on December 29, 2010 for $120 million. | Health Technology |
S&R Foundation
S&R Foundation Miscellaneous Commercial ServicesCommercial Services The S&R Foundation provides support for artists and scientists involved in the arts, sciences, and social entrepreneurship, especially those furthering international and cultural collaboration. The company was founded by Sachiko Kuno and Ryuji Euno in 2000 and is headquartered in Washington, DC. | Commercial Services |
| Omotesenke Domonkai Eastern Region USA, Inc. | |
VLP Therapeutics LLC
VLP Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD. | Commercial Services |
